Zobrazeno 1 - 10
of 202
pro vyhledávání: '"BL Levine"'
Publikováno v:
Klinische Pädiatrie. 216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fc7c045d0c0bfb381f0b2db85064212
https://doi.org/10.1055/s-2004-828590
https://doi.org/10.1055/s-2004-828590
Autor:
Zhao Y, Moon E, Carpenito C, Paulos CM, Liu X, Brennan AL, Chew A, Carroll RG, Scholler J, Levine BL, Albelda SM, June CH
Publikováno v:
Cancer research [Cancer Res] 2024 Nov 04; Vol. 84 (21), pp. 3702.
Autor:
Jadlowsky JK; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania., Chang JF; Center for Gene and Cellular Immunotherapy, Washington University School of Medicine, St. Louis, Missouri.; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri., Spencer DH; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri., Warrington JM; Center for Gene and Cellular Immunotherapy, Washington University School of Medicine, St. Louis, Missouri.; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri., Levine BL; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., June CH; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Fraietta JA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania., Singh N; Center for Gene and Cellular Immunotherapy, Washington University School of Medicine, St. Louis, Missouri.; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2024 Sep 03; Vol. 12 (9), pp. 1132-1135.
Autor:
Klapwijk JC; Cornelis Consulting Ltd, London, United Kingdom., Del Rio Espinola A; GentiBio Inc., Cambridge, Massachusetts, USA., Libertini S; Novartis Biomedical Research, Basel, Switzerland., Collin P; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Fellows MD; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Jobling S; TestaVec Ltd, Maidenhead, United Kingdom.; Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom., Lynch AM; GlaxoSmithKline, Genetic Toxicology, Ware, United Kingdom., Martus H; Novartis Biomedical Research, Basel, Switzerland., Vickers C; National Centre for the Replacement Refinement and Reduction of Animals in Research, London, United Kingdom., Zeller A; F. Hoffmann-La Roche Ltd., pRED, Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Biasco L; UCL Zayed Centre for Research (ZCR), London, United Kingdom., Brugman MH; Cell and Gene Therapy, GSK Medicine Research Centre, Stevenage, United Kingdom., Bushmann FD; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, Pennsylvania, USA., Cathomen T; Institute for Transfusion Medicine and Gene Therapy, Medical Center- University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Ertl HCJ; Ertl Laboratory, Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, USA., Gabriel R; ProtaGene CGT, Heidelberg, Germany., Gao G; Horae Gene Therapy Center, UMass Chan Medical School, University of Massachusetts, Worcester, Massachusetts, USA., Jadlowsky JK; Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kimber I; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Lanz TA; Drug Safety Research & Development, Pfizer, Inc., Groton, Connecticut, USA., Levine BL; Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Micklethwaite KP; Department of Haematology, Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, Australia.; NSW Health Pathology Blood Transplant and Cell Therapies Laboratory - ICPMR Westmead, Sydney, Australia.; Westmead Institute for Medical Research, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia., Onodera M; Gene & Cell Therapy Promotion Center, National Center for Child Health and Development, Tokyo, Japan., Pizzurro DM; Merck & Co., Inc., Boston, Massachusetts, USA., Reed S; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom., Rothe M; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany., Sabatino DE; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Salk JJ; Department of Medicine, Divisions of Hematology and Medical Oncology, University of Washington School of Medicine, Seattle, Washington, USA.; TwinStrand Biosciences Inc., Seattle, Washington, USA., Schambach A; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Themis M; TestaVec Ltd, Maidenhead, United Kingdom.; Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom., Yuan J; Kymera Therapeutics, Watertown, Massachusetts, USA.
Publikováno v:
Human gene therapy [Hum Gene Ther] 2024 Aug; Vol. 35 (15-16), pp. 527-542.
Autor:
Pasdar MA; Children's National Hospital, Washington, DC, USA. Electronic address: pasdarma@gmail.com., Sivilotti MM; OmniaBio Inc., Toronto, Ontario, Canada., Jaehn PS; Catalent Pharma Solutions, Gosselies, Hainaut, Belgium., Baghbaderani BA; Lonza Biologics Inc., Houston, Texas, USA., Lee J; Center for Breakthrough Medicines, King of Prussia, Pennsylvania, USA., Levine BL; Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA., Milligan WD; Steminent Biotherapeutics Inc., Vancouver, British Columbia, Canada.
Publikováno v:
Cytotherapy [Cytotherapy] 2024 Jul; Vol. 26 (7), pp. 656-659. Date of Electronic Publication: 2024 Mar 11.
Autor:
Tebas P, Jadlowsky JK, Shaw PA, Tian L, Esparza E, Brennan AL, Kim S, Naing SY, Richardson MW, Vogel AN, Maldini CR, Kong H, Liu X, Lacey SF, Bauer AM, Mampe F, Richman LP, Lee G, Ando D, Levine BL, Porter DL, Zhao Y, Siegel DL, Bar KJ, June CH, Riley JL
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2024 May 01; Vol. 134 (9). Date of Electronic Publication: 2024 May 01.
Autor:
Ghilardi G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Fraietta JA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Gerson JN; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Van Deerlin VM; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Personalized Diagnostics, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Morrissette JJD; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Personalized Diagnostics, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Caponetti GC; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Paruzzo L; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Harris JC; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Susanibar Adaniya SP; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Ugwuanyi OH; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Fardella E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Waxman AJ; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Chong ER; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Patel V; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Pajarillo R; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Kulikovskaya I; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Lieberman DB; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Personalized Diagnostics, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Cohen AD; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Levine BL; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Stadtmauer EA; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Frey NV; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Vogl DT; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Hexner EO; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Porter DL; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Garfall AL; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., June CH; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA., Ruella M; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.
Publikováno v:
Nature medicine [Nat Med] 2024 Apr; Vol. 30 (4), pp. 984-989. Date of Electronic Publication: 2024 Jan 24.
Autor:
Levine BL; Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA. levinebl@pennmedicine.upenn.edu., Pasquini MC; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA., Connolly JE; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Porter DL; Cell Therapy and Transplant, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Gustafson MP; Department of Laboratory Medicine and Pathology, Mayo Clinic in Arizona, Phoenix, AZ, USA., Boelens JJ; Transplantation and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Horwitz EM; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA., Grupp SA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Maus MV; Cellular Immunotherapy Program, Mass General Cancer Center and Harvard Medical School, Cambridge, MA, USA., Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA., Ciceri F; University Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute Milano, Milan, Italy., Ruggeri A; Hematology and BMT unit, IRCCS San Raffaele scientific institute, Milano, Italy., Snowden J; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK., Heslop HE; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.; Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute and Departments of Pediatrics and Medicine, Stanford University, Palo Alto, CA, USA.; Parker Institute for Cancer Immunotherapy, Palo Alto, CA, USA., June CH; Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA., Sureda AM; Clinical Hematology Department, Institut Català d'Oncologia - L'Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain., Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Publikováno v:
Nature medicine [Nat Med] 2024 Feb; Vol. 30 (2), pp. 338-341.
Autor:
Wang K; Georgia Tech Manufacturing Institute, Georgia Institute of Technology, Atlanta, Georgia, USA. Electronic address: kan.wang@gatech.edu., Tseng CY; Georgia Tech Manufacturing Institute, Georgia Institute of Technology, Atlanta, Georgia, USA; School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA. Electronic address: ctseng40@gatech.edu., Li Z; H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA., White C; H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA., Wang B; Georgia Tech Manufacturing Institute, Georgia Institute of Technology, Atlanta, Georgia, USA; H. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA; School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA., Levine BL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Fesnak AD; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publikováno v:
Cytotherapy [Cytotherapy] 2023 Dec; Vol. 25 (12), pp. 1370-1379. Date of Electronic Publication: 2023 Sep 22.
Autor:
Noll JH; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Levine BL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Fraietta JA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: jfrai@upenn.edu.
Publikováno v:
Seminars in immunology [Semin Immunol] 2023 Nov; Vol. 70, pp. 101840. Date of Electronic Publication: 2023 Sep 18.